Global Left Atrial Appendage Closure Device Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Left Atrial Appendage Closure Device Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

The left atrial appendage (LAA) is a small, ear-shaped sac in the muscle wall of the left atrium (top left chamber of the heart).

Market Overview:

The latest research study on the global Left Atrial Appendage Closure Device market finds that the global Left Atrial Appendage Closure Device market reached a value of USD 2143.03 million in 2022. It’s expected that the market will achieve USD 12344.62 million by 2028, exhibiting a CAGR of 33.89% during the forecast period.

Drivers

Atrial fibrillation (AF) is one of the most common arrhythmias in the clinic, with the incidence increasing with age. After research, the use of a special left atrial appendage occlusion device to occlude the left atrial appendage, thereby achieving the purpose of preventing thromboembolism of atrial fibrillation, is a treatment method with less trauma, simple operation and less time-consuming treatment developed in recent years. Many scholars have devoted themselves to the application of this technology to prevent thromboembolism in atrial fibrillation, and have made great progress.
The prevalence of atrial fibrillation in the elderly population is primarily driving the development of the global LAA closure device market. In addition, the government's surge in public awareness of cardiovascular disease has contributed to market growth. However, strict government regulation of the LAA closure system has hampered this growth. Technological advances in LAA closures can further drive the LAA closure market.

Opportunities

Improve performance
With the progress in science and technology, more advanced materials and production methods, investment of companies, there will be more cost effective, high performance products.
Because LACC fundamentally solves the problem of thrombosis, although the cost of surgery is high, it avoids the cost of long-term medication and the side effects of drugs. As the government attaches importance to health issues, it further increases the demand for LACC equipment.
Emerging countries
For example, China, India are developing their industries, with the progress of economy and technology, the increasing demand downstream, such as the increase of Medical industry, the market of Left Atrial Appendage Closure Device has great market potential in the future.

Region Overview:

In 2022, the share of the Left Atrial Appendage Closure Device market in Europe stood at 58.93%.

Company Overview:

Boston Scientific Corporation is one of the major players operating in the Left Atrial Appendage Closure Device market, holding a share of 39.7% in 2021.

Boston Scientific Corporation

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg.

Abbott Laboratories

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company’s Established Pharmaceutical Products

Segmentation Overview:

By type, Endocardial LAA Closure Device segment accounted for the largest share of market in 2022.

Application Overview:

By application, the Hospital segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Left Atrial Appendage Closure Device market covered in Chapter 3:

SentreHEART, Inc.
Cardia Inc.
Abbott Laboratories
Occlutech GmbH
Lifetech Scientific, Co. Ltd
Johnson & Johnson
AtriCure, Inc.
Boston Scientific Corporation

In Chapter 4 and Chapter 14.2, on the basis of types, the Left Atrial Appendage Closure Device market from 2018 to 2029 is primarily split into:

Epicardial LAA Closure Device
Endocardial LAA Closure Device

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Left Atrial Appendage Closure Device market from 2018 to 2029 covers:

Hospital
Clinic
Other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)